AIDS Diagnostics Market in USA Reviewed in New Comprehensive Study Published by MarketPublishers.com

03 Nov 2011 • by Natalie Aster

LONDON – AIDS Diagnostics Market is spreading year-on-year along with the need to diagnose the population as a large number of people are unaware that they are infected with HIV. With the number of infection instances in the USA on rise, the market for diagnostics of AIDS is also expanding.

New market research study “The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Shares” worked out by Venture Planning Group has been recently published by Market Publishers Ltd.

Report Details:

Title: The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Sharesbr> Published: October, 2011
Pages: 251
Price: US$ 1,850

The research presents an in-depth analysis of the US AIDS diagnostics market, it offers comprehensive information on test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests. The tests reviewed are performed in such segments as:

• Hospitals
• Commercial/Private Laboratories
• Blood Banks
• Physician Offices
• Public Health Laboratories

The report presents sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, Ortho Clinical Diagnostics, Novartis, and Roche.

Reports Contents:

I. INTRODUCTION

II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS'
Sales and Market Shares

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe

…

More new market research reports by the publisher can be found at Venture Planning Group page.

CONTACTS

The Market Publishers, Ltd.

Mrs. Tanya Rezler

Tel: +44 208 123 2220

Fax: +44 207 900 3970

[email protected]

www.marketpublishers.com